Heghine Khachatryan: A Valuable Educational Resource on Inhibitor Development
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
“An outstanding educational initiative.
As gene therapy continues to transform haemophilia care, a deeper understanding of inhibitor development remains fundamental to ensuring both efficacy and long-term safety.
Thank you for this valuable educational resource.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed our latest Gene Therapy online session or want to rewatch it?
The full replay of ‘Inhibitor Development in Gene Therapy for Haemophilia’ is now available on the EAHAD Academy.
And stay tuned for our next Gene Therapy webinar!”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jul 4, 2026, 11:42Roshni Kulkarni: Study Underscores the Urgent Need to Prevent Postpartum Hemorrhage Deaths
-
Jul 4, 2026, 11:25Michael Cahillane: Latest Transfusion Medicine Research Takes Center Stage at ISBT Congress
-
Jul 4, 2026, 11:10Henning Nilius: Career Milestone Reached with FAMH Specialist Certification
-
Jul 4, 2026, 10:56Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
-
Jul 4, 2026, 09:44Ettore Nicolini: Optimizing First-Pass Reperfusion in Basilar Artery Occlusion
-
Jul 4, 2026, 09:15Niroshani Young: The Essentials of Safe Blood Component Transfusion
-
Jul 4, 2026, 08:48Satarupa Choudhuri: Personalizing Anticoagulation Duration After VTE
-
Jul 4, 2026, 07:41Reem Alotaibi: Hexokinase as a Regulator of Platelet Metabolism and Function
-
Jul 4, 2026, 07:10Andrew Zapfel: A New WHO Framework for Newborn Screening in Low and Middle-Income Countries